BIOGEN INC. Net Income (Loss) Attributable to Noncontrolling Interest
BIOGEN INC. (BIIB) reported Net Income (Loss) Attributable to Noncontrolling Interest of $0 for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Income Statement › Net Income
us-gaap:NetIncomeLossAttributableToNoncontrollingInterest · last filed 2026-02-06
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-12-31 was $0.00.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-09-30 was $0.00.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-06-30 was $0.00, a 100.00% decline year-over-year.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for the quarter ending 2024-03-31 was $0.00.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for fiscal 2025 was $0.00.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for fiscal 2024 was $0.00, a 100.00% decline from fiscal 2023.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for fiscal 2023 was $400.00K.
- BIOGEN INC. net income (loss) attributable to noncontrolling interest for fiscal 2022 was -$85.30M, a 149.74% decline from fiscal 2021.
| Period end | Net Income (Loss) Attributable to Noncontrolling Interest 3 month | Net Income (Loss) Attributable to Noncontrolling Interest 3 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 6 month | Net Income (Loss) Attributable to Noncontrolling Interest 6 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 9 month | Net Income (Loss) Attributable to Noncontrolling Interest 9 month as first filed | Net Income (Loss) Attributable to Noncontrolling Interest 12 month | Net Income (Loss) Attributable to Noncontrolling Interest 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $0.00 10-K · filed 2026-02-06 | |||||||
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $0.00 derived: sum of 2 quarters · filed 2026-02-06 | $0.00 derived: sum of 3 quarters · filed 2026-02-06 | $0.00 10-K · filed 2026-02-06 | ||||
| 2024-09-30 | $0.00 10-Q · filed 2024-10-30 | $0.00 derived: sum of 2 quarters · filed 2024-10-30 | $0.00 10-Q · filed 2024-10-30 | -$800.00K derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-06-30 | $0.00 10-Q · filed 2024-08-01 | $0.00 10-Q · filed 2024-08-01 | -$800.00K derived: sum of 3 quarters · filed 2026-02-06 | -$1.00M derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2024-03-31 | $0.00 10-Q · filed 2024-04-24 | -$800.00K derived: sum of 2 quarters · filed 2026-02-06 | -$1.00M derived: sum of 3 quarters · filed 2026-02-06 | $700.00K derived: sum of 4 quarters · filed 2026-02-06 | ||||
| 2023-12-31 | -$800.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | -$1.00M derived: sum of 2 quarters · filed 2026-02-06 | $700.00K derived: sum of 3 quarters · filed 2026-02-06 | $400.00K 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | -$200.00K 10-Q · filed 2024-10-30 | $1.50M derived: sum of 2 quarters · filed 2024-10-30 | $1.20M 10-Q · filed 2024-10-30 | $300.00K derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-06-30 | $1.70M 10-Q · filed 2024-08-01 | $1.40M 10-Q · filed 2024-08-01 | $500.00K derived: sum of 3 quarters · filed 2025-02-12 | $700.00K derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2023-03-31 | -$300.00K 10-Q · filed 2024-04-24 | -$1.20M derived: sum of 2 quarters · filed 2025-02-12 | -$1.00M derived: sum of 3 quarters · filed 2025-02-12 | -$300.00K derived: sum of 4 quarters · filed 2025-02-12 | ||||
| 2022-12-31 | -$900.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-12 | -$700.00K derived: sum of 2 quarters · filed 2025-02-12 | $0.00 derived: sum of 3 quarters · filed 2025-02-12 | -$85.30M 10-K · filed 2025-02-12 | ||||
| 2022-09-30 | $200.00K 10-Q · filed 2023-11-08 | $900.00K derived: sum of 2 quarters · filed 2023-11-08 | -$84.40M 10-Q · filed 2023-11-08 | -$473.10M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-06-30 | $700.00K 10-Q · filed 2023-07-25 | -$84.60M 10-Q · filed 2023-07-25 | -$473.30M derived: sum of 3 quarters · filed 2024-02-14 | -$484.40M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2022-03-31 | -$85.30M 10-Q · filed 2023-04-25 | -$474.00M derived: sum of 2 quarters · filed 2024-02-14 | -$485.10M derived: sum of 3 quarters · filed 2024-02-14 | $91.90M derived: sum of 4 quarters · filed 2024-02-14 | ||||
| 2021-12-31 | -$388.70M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$399.80M derived: sum of 2 quarters · filed 2024-02-14 | $177.20M derived: sum of 3 quarters · filed 2024-02-14 | $171.50M 10-K · filed 2024-02-14 | ||||
| 2021-09-30 | -$11.10M 10-Q · filed 2022-10-25 | $565.90M derived: sum of 2 quarters · filed 2022-10-25 | $560.20M 10-Q · filed 2022-10-25 | $560.00M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-06-30 | $577.00M 10-Q · filed 2022-07-20 | $571.40M 10-Q · filed 2022-07-20 | $571.10M derived: sum of 3 quarters · filed 2023-02-15 | $573.50M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2021-03-31 | -$5.60M 10-Q · filed 2022-05-03 | -$5.90M derived: sum of 2 quarters · filed 2023-02-15 | -$3.50M derived: sum of 3 quarters · filed 2023-02-15 | $60.90M derived: sum of 4 quarters · filed 2023-02-15 | ||||
| 2020-12-31 | -$300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-15 | $2.10M derived: sum of 2 quarters · filed 2023-02-15 | $66.50M derived: sum of 3 quarters · filed 2023-02-15 | $59.90M 10-K · filed 2023-02-15 | ||||
| 2020-09-30 | $2.40M 10-Q · filed 2021-10-20 | $66.80M derived: sum of 2 quarters · filed 2021-10-20 | $60.20M 10-Q · filed 2021-10-20 | $60.30M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-06-30 | $64.40M 10-Q · filed 2021-07-22 | $57.80M 10-Q · filed 2021-07-22 | $57.90M derived: sum of 3 quarters · filed 2022-02-03 | $57.90M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2020-03-31 | -$6.50M 10-Q · filed 2021-04-22 | -$6.50M derived: sum of 2 quarters · filed 2022-02-03 | -$6.50M derived: sum of 3 quarters · filed 2022-02-03 | -$6.50M derived: sum of 4 quarters · filed 2022-02-03 | ||||
| 2019-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-03 | $0.00 derived: sum of 2 quarters · filed 2022-02-03 | $0.00 derived: sum of 3 quarters · filed 2022-02-03 | $0.00 10-K · filed 2022-02-03 | ||||
| 2019-09-30 | $0.00 10-Q · filed 2020-10-21 | $0.00 derived: sum of 2 quarters · filed 2020-10-21 | $0.00 10-Q · filed 2020-10-21 | -$1.90M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-22 | $0.00 10-Q · filed 2020-07-22 | -$1.90M derived: sum of 3 quarters · filed 2021-02-03 | -$3.40M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2019-03-31 | $0.00 10-Q · filed 2020-04-23 | -$1.90M derived: sum of 2 quarters · filed 2021-02-03 | -$3.40M derived: sum of 3 quarters · filed 2021-02-03 | $45.00M derived: sum of 4 quarters · filed 2021-02-03 | ||||
| 2018-12-31 | -$1.90M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-03 | -$3.40M derived: sum of 2 quarters · filed 2021-02-03 | $45.00M derived: sum of 3 quarters · filed 2021-02-03 | $43.30M 10-K · filed 2021-02-03 | ||||
| 2018-09-30 | -$1.50M 10-Q · filed 2019-10-22 | $46.90M derived: sum of 2 quarters · filed 2019-10-22 | $45.20M 10-Q · filed 2019-10-22 | $176.30M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-06-30 | $48.40M 10-Q · filed 2019-07-24 | $46.70M 10-Q · filed 2019-07-24 | $177.80M derived: sum of 3 quarters · filed 2020-02-06 | $177.80M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2018-03-31 | -$1.70M 10-Q · filed 2019-04-24 | $129.40M derived: sum of 2 quarters · filed 2020-02-06 | $129.40M derived: sum of 3 quarters · filed 2020-02-06 | $129.40M derived: sum of 4 quarters · filed 2020-02-06 | ||||
| 2017-12-31 | $131.10M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-06 | $131.10M derived: sum of 2 quarters · filed 2020-02-06 | $131.10M derived: sum of 3 quarters · filed 2020-02-06 | $131.00M 10-K · filed 2020-02-06 | ||||
| 2017-09-30 | $0.00 10-Q · filed 2018-10-23 | $0.00 derived: sum of 2 quarters · filed 2018-10-23 | -$100.00K 10-Q · filed 2018-10-23 | -$1.40M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-06-30 | $0.00 10-Q · filed 2018-07-24 | -$100.00K 10-Q · filed 2018-07-24 | -$1.40M derived: sum of 3 quarters · filed 2019-02-06 | -$4.10M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2017-03-31 | -$100.00K 10-Q · filed 2018-04-24 | -$1.40M derived: sum of 2 quarters · filed 2019-02-06 | -$4.10M derived: sum of 3 quarters · filed 2019-02-06 | -$5.50M derived: sum of 4 quarters · filed 2019-02-06 | ||||
| 2016-12-31 | -$1.30M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-06 | -$4.00M derived: sum of 2 quarters · filed 2019-02-06 | -$5.40M derived: sum of 3 quarters · filed 2019-02-06 | -$7.10M 10-K · filed 2019-02-06 | ||||
| 2016-09-30 | -$2.70M 10-Q · filed 2017-10-24 | -$4.10M derived: sum of 2 quarters · filed 2017-10-24 | -$5.80M 10-Q · filed 2017-10-24 | -$8.70M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-06-30 | -$1.40M 10-Q · filed 2017-07-25 | -$3.10M 10-Q · filed 2017-07-25 | -$6.00M derived: sum of 3 quarters · filed 2018-02-01 | $47.90M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2016-03-31 | -$1.70M 10-Q · filed 2017-04-25 | -$4.60M derived: sum of 2 quarters · filed 2018-02-01 | $49.30M derived: sum of 3 quarters · filed 2018-02-01 | $46.80M derived: sum of 4 quarters · filed 2018-02-01 | ||||
| 2015-12-31 | -$2.90M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-01 | $51.00M derived: sum of 2 quarters · filed 2018-02-01 | $48.50M derived: sum of 3 quarters · filed 2018-02-01 | $46.20M 10-K · filed 2018-02-01 | ||||
| 2015-09-30 | $53.90M 10-Q · filed 2016-10-26 | $53.87M 10-Q · filed 2015-10-21 | $51.40M derived: sum of 2 quarters · filed 2016-10-26 | $49.10M 10-Q · filed 2016-10-26 | $49.05M 10-Q · filed 2015-10-21 | $48.14M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-06-30 | -$2.50M 10-Q · filed 2016-07-21 | -$2.45M 10-Q · filed 2015-07-24 | -$4.80M 10-Q · filed 2016-07-21 | -$4.82M 10-Q · filed 2015-07-24 | -$5.76M derived: sum of 3 quarters · filed 2017-02-02 | -$6.50M derived: sum of 4 quarters · filed 2017-02-02 | ||
| 2015-03-31 | -$2.40M 10-Q · filed 2016-04-21 | -$2.37M 10-Q · filed 2015-04-24 | -$3.26M derived: sum of 2 quarters · filed 2017-02-02 | -$4.00M derived: sum of 3 quarters · filed 2017-02-02 | $4.63M derived: sum of 4 quarters · filed 2017-02-02 | |||
| 2014-12-31 | -$860.00K derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-02 | -$1.60M derived: sum of 2 quarters · filed 2017-02-02 | $7.03M derived: sum of 3 quarters · filed 2017-02-02 | $6.80M 10-K · filed 2017-02-02 | $6.78M 10-K · filed 2015-02-04 | |||
| 2014-09-30 | -$738.00K 10-Q · filed 2015-10-21 | $7.89M derived: sum of 2 quarters · filed 2015-10-21 | $7.66M 10-Q · filed 2015-10-21 | $7.66M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-06-30 | $8.63M 10-Q · filed 2015-07-24 | $8.40M 10-Q · filed 2015-07-24 | $8.40M derived: sum of 3 quarters · filed 2016-02-03 | $8.40M derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2014-03-31 | -$228.00K 10-Q · filed 2015-04-24 | -$228.00K derived: sum of 2 quarters · filed 2016-02-03 | -$228.00K derived: sum of 3 quarters · filed 2016-02-03 | -$228.00K derived: sum of 4 quarters · filed 2016-02-03 | ||||
| 2013-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-03 | $0.00 derived: sum of 2 quarters · filed 2016-02-03 | $0.00 derived: sum of 3 quarters · filed 2016-02-03 | $0.00 10-K · filed 2016-02-03 | ||||
| 2013-09-30 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 2 quarters · filed 2014-10-22 | $0.00 10-Q · filed 2014-10-22 | $0.00 derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-06-30 | $0.00 10-Q · filed 2014-07-23 | $0.00 10-Q · filed 2014-07-23 | $0.00 derived: sum of 3 quarters · filed 2015-02-04 | $0.00 derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2013-03-31 | $0.00 10-Q · filed 2014-04-23 | $0.00 derived: sum of 2 quarters · filed 2015-02-04 | $0.00 derived: sum of 3 quarters · filed 2015-02-04 | $295.00K derived: sum of 4 quarters · filed 2015-02-04 | ||||
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-04 | $0.00 derived: sum of 2 quarters · filed 2015-02-04 | $295.00K derived: sum of 3 quarters · filed 2015-02-04 | $0.00 10-K · filed 2015-02-04 | ||||
| 2012-09-30 | $0.00 10-Q · filed 2013-10-28 | $295.00K derived: sum of 2 quarters · filed 2013-10-28 | $0.00 10-Q · filed 2013-10-28 | -$28.00K derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-06-30 | $295.00K 10-Q · filed 2013-07-25 | $0.00 10-Q · filed 2013-07-25 | -$28.00K derived: sum of 3 quarters · filed 2014-02-06 | $1.81M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2012-03-31 | -$295.00K 10-Q · filed 2013-04-25 | -$323.00K derived: sum of 2 quarters · filed 2014-02-06 | $1.51M derived: sum of 3 quarters · filed 2014-02-06 | $17.53M derived: sum of 4 quarters · filed 2014-02-06 | ||||
| 2011-12-31 | -$28.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-02-06 | $1.81M derived: sum of 2 quarters · filed 2014-02-06 | $17.82M derived: sum of 3 quarters · filed 2014-02-06 | $32.26M 10-K · filed 2014-02-06 | ||||
| 2011-09-30 | $1.84M 10-Q · filed 2012-10-25 | $17.85M derived: sum of 2 quarters · filed 2012-10-25 | $32.29M 10-Q · filed 2012-10-25 | $63.79M derived: sum of 4 quarters · filed 2012-10-25 | ||||
| 2011-06-30 | $16.02M 10-Q · filed 2012-07-24 | $30.45M 10-Q · filed 2012-07-24 | $61.95M derived: sum of 3 quarters · filed 2012-07-24 | -$79.99M derived: sum of 4 quarters · filed 2012-07-24 | ||||
| 2011-03-31 | $14.44M 10-Q · filed 2012-05-01 | $45.94M derived: sum of 2 quarters · filed 2012-05-01 | -$96.00M derived: sum of 3 quarters · filed 2012-05-01 | -$94.79M derived: sum of 4 quarters · filed 2012-05-01 | ||||
| 2010-12-31 | $31.50M 10-K · filed 2011-02-04 | -$110.44M derived: sum of 2 quarters · filed 2011-10-28 | -$109.22M derived: sum of 3 quarters · filed 2011-10-28 | -$106.70M 10-K · filed 2013-02-05 | ||||
| 2010-09-30 | -$141.94M 10-Q · filed 2011-10-28 | -$140.72M derived: sum of 2 quarters · filed 2011-10-28 | -$138.17M 10-Q · filed 2011-10-28 | -$137.77M derived: sum of 4 quarters · filed 2011-10-28 | ||||
| 2010-06-30 | $1.21M 10-Q · filed 2011-07-26 | $3.76M 10-Q · filed 2011-07-26 | $4.16M derived: sum of 3 quarters · filed 2011-07-26 | $6.06M derived: sum of 4 quarters · filed 2011-07-26 | ||||
| 2010-03-31 | $2.55M 10-Q · filed 2011-04-21 | $2.95M derived: sum of 2 quarters · filed 2011-04-21 | $4.85M derived: sum of 3 quarters · filed 2011-04-21 | $6.85M derived: sum of 4 quarters · filed 2011-04-21 | ||||
| 2009-12-31 | $400.00K 10-K · filed 2011-02-04 | $2.30M derived: sum of 2 quarters · filed 2011-02-04 | $4.30M derived: sum of 3 quarters · filed 2011-02-04 | $6.93M 10-K · filed 2012-02-03 | ||||
| 2009-09-30 | $1.90M 10-K · filed 2011-02-04 | $1.94M 10-Q · filed 2009-10-21 | $3.90M derived: sum of 2 quarters · filed 2011-02-04 | $6.57M 10-Q · filed 2010-10-26 | $8.27M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-06-30 | $2.00M 10-K · filed 2011-02-04 | $2.04M 10-Q · filed 2010-07-20 | $4.63M 10-Q · filed 2010-07-20 | $6.37M derived: sum of 3 quarters · filed 2011-02-04 | $7.38M derived: sum of 4 quarters · filed 2011-02-04 | |||
| 2009-03-31 | $2.60M 10-K · filed 2011-02-04 | $2.59M 10-Q · filed 2010-04-20 | $4.37M derived: sum of 2 quarters · filed 2011-02-04 | $5.38M derived: sum of 3 quarters · filed 2011-02-04 | ||||
| 2008-12-31 | $1.77M derived: 10-K 12 month − 10-Q 9 month · filed 2011-02-04 | $2.79M derived: sum of 2 quarters · filed 2011-02-04 | $6.94M 10-K · filed 2011-02-04 | |||||
| 2008-09-30 | $1.01M 10-Q · filed 2009-10-21 | $5.17M 10-Q · filed 2009-10-21 | ||||||
| 2007-12-31 | -$58.43M 10-K · filed 2010-02-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Revolution Medicines, Inc. (RVMD) | United States | $42.805B | -22.69 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |